Location History:
- Del Mark, CA (US) (2007)
- Boston, MA (US) (2015)
- Del Mar, CA (US) (2004 - 2016)
Company Filing History:
Years Active: 2004-2016
Title: **Katherine S Bowdish: Pioneering Innovations in Antibody Development**
Introduction
Katherine S Bowdish is a distinguished inventor based in Del Mar, CA, known for her significant contributions to the field of biomedicine. With an impressive portfolio of 27 patents, she has made notable advancements in antibody design and cancer therapies.
Latest Patents
Among her latest innovations, Bowdish has developed rationally designed antibodies that feature complementary determining regions (CDR) replaced or fused with biologically active peptides. These antibodies may include flanking sequences attached at the carboxy-terminal and amino-terminal ends of the peptide, ensuring a covalent association with adjacent framework regions. Such advancements are not only groundbreaking but are poised to be instrumental in various therapeutic and diagnostic applications. Additionally, her patent involving polypeptides and antibodies derived from chronic lymphocytic leukemia cells focuses on a dual therapeutic approach. This therapy aims to disrupt the interaction between CD200 and its receptor, thus promoting the eradication of cancer cells and directly eliminating them through various mechanisms, including complement-mediated or antibody-dependent cellular cytotoxicity.
Career Highlights
Katherine currently works at Alexion Pharmaceuticals, Inc., where she continues her cutting-edge research and development in immunotherapy. Her role at this prestigious company allows her to translate her innovative ideas into tangible medical solutions that address critical health challenges.
Collaborations
Throughout her career, Katherine has collaborated with respected professionals like John R McWhirter and Anke Kretz-Rommel. These partnerships have been vital in enhancing her research, providing diverse insights, and accelerating the development of promising therapies.
Conclusion
With a robust patent portfolio and a commitment to advancing medical innovation, Katherine S Bowdish exemplifies the impact that dedicated inventors can have on healthcare and biotechnology. Her work not only contributes to scientific knowledge but also offers hope for effective cancer treatments through her pioneering research in antibody technology.